Fundz

Cepheid

Sunnyvale, United States · Biotechnology, Genetics, Health Care

Cepheid is dedicated to improving healthcare by pioneering molecular diagnostics that combine speed, accuracy, and flexibility. The company's GeneXpert® systems and Xpert® tests automate highly complex and time-consuming manual procedures, providing A Better Way for institutions of any size to perform world-class PCR testing. Cepheid’s broad test portfolio spans respiratory infections, blood virol

Recent signals

  • Apr 15, 2026: Launched Cepheid launches an expanded workflow for infectious disease research in partnership with Oxford Nanopore.
  • Nov 22, 2024: Cepheid Bags $1.8 million Contract
  • Jul 30, 2024: Cepheid Clinches $685.4 thousand Contract
  • May 23, 2023: Cepheid Announces Vitor Rocha as President

See plans & pricing → Track Cepheid’s funding, hiring, and signals — with verified contacts — on Fundz.